In vitro activity of chloramphenicol, florfenicol and enrofloxacin against<i>Chlamydia pecorum</i>isolated from koalas (<i>Phascolarctos cinereus</i>)

Abstract

When combined with previously published pharmacokinetic data, the in vitro susceptibility results support chloramphenicol as a more appropriate treatment option than enrofloxacin for koalas with chlamydiosis. The susceptibility results also indicate florfenicol may be an appropriate treatment option for koalas with chlamydiosis, warranting further investigation.